fda pulls semaglutide 📢 has determined the shortage of injection products, a glucagon-like peptide 1 (GLP-1) medication, is resolved. Patients and prescribers may still see intermittent and limited localized supply disruptions as the FDA Warns on Certain Forms

Ozempic (semaglutide), originally a diabetes medication, is now widely prescribed for weight loss

FDA Sends Warning Letters to More Than 50 GLP-1 Compounders and Manufacturers

We discuss what science actually tells us about how to improve our learning ability and memory at any age

Think of peptides as specific messengers that give your cells instructions

This fiscal burden transcends the issues of accessibility in low-income regions, necessitating a thorough health economic assessment across various healthcare systems

The Precision Peptide Genetic Test maps pathway-level variants in GLP1R, FTO, and MC4R that describe your baseline metabolism